(MedPage Today) — While still considered a rare disease, transthyretin amyloid cardiomyopathy (ATTR-CM) is nevertheless emerging in more people than previously thought due to increased interest and improved access to diagnostic tools.
In one…
Source link : https://www.medpagetoday.com/spotlight/attr-cm/117267
Author :
Publish date : 2025-09-02 18:48:00
Copyright for syndicated content belongs to the linked Source.
